Skip to main content

Table 3 Factors associated with non-invasive therapy by age category for the total sample and stratified by type of AMI

From: Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA Myocardial Infarction Registry

 

Age category

25–64 years

65–74 years

75–84 years

OR [95 % CI]

p Value

OR [95 % CI]

p Value

OR [95 % CI]

p Value

Total sample (n = 3452)a

(n = 1324)

(n = 1077)

(n = 1051)

 Sex (women vs. men)

1.28 [0.80–2.06]

0.30

1.80 [1.24–2.61]

0.002

1.38 [1.03–1.85]

0.03

 Type of AMI (NSTEMI vs. STEMI)

3.07 [1.81–5.20]

<0.0001

2.54 [1.59–4.05]

<0.0001

2.36 [1.59–3.51]

<0.0001

 Type of AMI (BBB vs. STEMI)

4.22 [1.76–10.1]

0.001

2.01 [1.05–3.84]

0.03

2.60 [1.58–4.26]

0.001

 Prior stroke (yes vs. no)

2.97 [1.40–6.30]

0.005

1.91 [1.17–3.13]

0.01

1.87 [1.27–2.75]

0.002

 Renal dysfunction (yes vs. no)

2.27 [1.06–4.90]

0.04

1.59 [1.03–2.45]

0.04

1.35 [0.97–1.87]

0.07

 Prior MI (yes vs. no)

2.08 [1.27–3.41]

0.004

2.00 [1.35–2.95]

0.001

1.27 [0.89–1.81]

0.18

 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %)

3.28 [1.60–6.71]

0.001

1.85 [1.02–3.35]

0.04

2.02 [1.30–3.14]

0.002

 LVEF (LVEF n/mb vs. LVEF > 30 %)

6.58 [4.05–10.7]

<0.0001

5.03 [3.32–7.63]

<0.0001

6.10 [4.27–8.73]

<0.0001

 History of hyperlipidemia (yes vs. no)

0.52 [0.34–0.80]

0.003

0.63 [0.44–0.90]

0.01

0.67 [0.49–0.91]

0.01

 History of COPD (yes vs. no)

1.89 [0.87–4.13]

0.11

2.26 [1.34–3.81]

0.002

0.83 [0.50–1.39]

0.48

 Peak serum CPK level (U/l) (continuous)

1.00 [1.00–1.00]

0.003

1.00 [1.00–1.00]

0.04

1.00 [1.00–1.00]

<0.0001

STEMI (n = 1292)

(n = 625)

(n = 369)

(n = 298)

 Sex (women vs. men)

n/ac

2.35 [1.06–5.21]

0.04

n/ac

 Prior stroke (yes vs. no)

11.2 [2.58–48.7]

0.001

n/ac

n/ac

 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %)

3.71 [1.01–13.6]

0.05

2.36 [0.74–7.54]

0.15

1.53 [0.58–4.03]

0.39

 LVEF (LVEF n/mb vs. LVEF > 30 %)

4.13 [1.22–14.0]

0.02

3.90 [1.30–11.7]

0.02

13.0 [5.72–29.3]

<0.0001

NSTEMI (n = 1838)

(n = 647)

(n = 603)

(n = 588)

 Sex (women vs. men)

n/ac

1.63 [1.04–2.53]

0.03

n/ac

 

 Prior stroke (yes vs. no)

n/ac

n/ac

2.15 [1.34–3.46]

0.002

 Renal dysfunction (yes vs. no)

2.76 [1.18–6.45]

0.02

1.80 [1.09–2.99]

0.02

n/ac

 Prior MI (yes vs. no)

1.81 [1.03–3.18]

0.04

2.04 [1.30–3.21]

0.002

n/ac

 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %)

3.08 [1.15–8.22]

0.03

1.88 [0.86–4.13]

0.12

3.19 [1.75–5.80]

0.001

 LVEF (LVEF n/mb vs. LVEF > 30 %)

6.24 [3.56–10.9]

<0.0001

5.04 [3.12–8.16]

<0.0001

5.49 [3.54–8.50]

<0.0001

 History of hyperlipidemia (yes vs. no)

0.52 [0.32–0.85]

0.01

n/ac

0.51 [0.35–0.74]

0.001

 History of COPD (yes vs. no)

2.57 [1.05–6.32]

0.04

2.11 [1.16–3.85]

0.01

n/ac

 Peak serum CPK level (U/l) (continuous)

1.00 [1.00–1.00]

0.001

n/ac

1.00 [1.00–1.00]

0.005

BBB (n = 330)

(n = 53)

(n = 111)

(n = 165)

 Prior MI (yes vs. no)

9.18 [1.62–51.9]

0.01d

3.17 [1.10–9.12]

0.03

n/ac

 Renal dysfunction (yes vs. no)

18.8 [1.04–340.0]

0.05d

n/ac

n/ac

 History of hypertension (yes vs. no)

0.11 [0.02–0.68]

0.02d

n/ac

n/ac

 LVEF (LVEF ≤ 30 % vs. LVEF > 30 %)

N/Ae

2.41 [0.65–8.99]

0.19

1.14 [0.46–2.83]

0.79

 LVEF (LVEF n/mb vs. LVEF > 30 %)

N/Ae

10.5 [3.27–33.7]

<0.0001

9.44 [3.89–22.9]

<0.0001

 Peak serum CPK level (U/l) (continuous

n/ac

n/ac

1.00 [1.00–1.00]

0.01

  1. The multivariable analysis included as explanatory variables sex, type of AMI (‘dummy’-coded), LVEF (‘dummy’-coded), renal dysfunction, prior stroke, prior MI, history of diabetes, hypertension, hyperlipidemia, angina pectoris and COPD, pre-hospital time, and peak serum CPK level. In the total sample, variables which meet the 0.05 significance level in at least one age category were included and presented. For the sub-samples by type of AMI only the significant factors in that sub-sample model (forward stepwise selection technique) were included and presented
  2. OR odds ratio, CI confidence interval, AMI acute myocardial infarction, STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, BBB bundle branch block, LVEF left ventricular ejection fraction, COPD chronic obstructive pulmonary disease, CPK creatine phosphokinase
  3. a As 23 patients had no data on peak serum CPK level, the total sample size was 3452 instead of 3475
  4. b n/m, LVEF were not assessed or missing
  5. c n/a, OR and p value were not applicable because the analyzed variable did not meet the 0.05 significance level for entry into the model of the sub-sample
  6. d P value and OR were assessed in a separate model without the variables regarding LVEF
  7. e N/A, not applicable due to quasi-complete separation of data points detected when ‘LVEF’ was included
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us